{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:44:16Z","timestamp":1792601056426,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc. Diabetol. \u2013 Endocrinol. Rep."],"DOI":"10.1186\/s40842-026-00311-6","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:02:18Z","timestamp":1781820138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pulmonary adverse events associated with GLP-1 receptor agonists: a systematic review of respiratory safety signals"],"prefix":"10.1186","volume":"12","author":[{"given":"Aarushi","family":"Ahuja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahana","family":"Manoharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arya","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansi","family":"Mody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FNU","family":"Paras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archita","family":"Archita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Shaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kartik","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Manoj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakashini","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhi","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pulkit","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"issue":"12","key":"311_CR1","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1080\/02770903.2024.2372600","volume":"61","author":"M Cazzola","year":"2024","unstructured":"Cazzola M, Matera MG, Calzetta L, Lauro D, Rogliani P. Can glucagon-like peptide-1 receptor agonists induce asthma? An analysis of the FAERS database. J Asthma. 2024;61(12):1638\u201345. https:\/\/doi.org\/10.1080\/02770903.2024.2372600.","journal-title":"J Asthma"},{"issue":"7","key":"311_CR2","doi-asserted-by":"publisher","first-page":"e250205","DOI":"10.1530\/EC-25-0205","volume":"14","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Li J, Zheng J, Liang Y, Ma L, Su L. Tirzepatide safety in type 2 diabetes: a disproportionality analysis of adverse events using the FDA FAERS database. Endocr Connect. 2025;14(7):e250205. https:\/\/doi.org\/10.1530\/EC-25-0205. Published 2025 Jul 24.","journal-title":"Endocr Connect"},{"issue":"4","key":"311_CR3","doi-asserted-by":"publisher","first-page":"e70077","DOI":"10.1111\/1753-0407.70077","volume":"17","author":"L Liu","year":"2025","unstructured":"Liu L, Cheng Z, Wang L, et al. Efficacy and Safety of Dulaglutide Biosimilar LY05008 Versus the Reference Product Dulaglutide (Trulicity) in Chinese Adults With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Active Comparator Study. J Diabetes. 2025;17(4):e70077. https:\/\/doi.org\/10.1111\/1753-0407.70077.","journal-title":"J Diabetes"},{"key":"311_CR4","doi-asserted-by":"publisher","unstructured":"Amin T, Mararenko A, Cheng J, Ong R, Holland S, Hu K. 8348 A rare case of liraglutide-associated angioedema requiring emergent intubation. J Endocr Soc. 2024;8(Suppl 1):bvae163.651. Published 2024 Oct 5. https:\/\/doi.org\/10.1210\/jendso\/bvae163.651.","DOI":"10.1210\/jendso\/bvae163.651"},{"key":"311_CR5","unstructured":"Grell Y, et al. Spontaneous pneumomediastinum associated with semaglutide-induced vomiting [conference abstract]. Am J Gastroenterol. 2024."},{"issue":"9","key":"311_CR6","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/S2213-8587(22)00187-5","volume":"10","author":"T Kadowaki","year":"2022","unstructured":"Kadowaki T, Chin R, Ozeki A, Imaoka T, Ogawa Y. Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial. Lancet Diabetes Endocrinol. 2022;10(9):634\u201344. https:\/\/doi.org\/10.1016\/S2213-8587(22)00187-5.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"311_CR7","doi-asserted-by":"publisher","first-page":"8289","DOI":"10.1038\/s41467-023-44067-4","volume":"14","author":"L Ji","year":"2023","unstructured":"Ji L, Jiang H, Cheng Z, et al. A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity. Nat Commun. 2023;14(1):8289. https:\/\/doi.org\/10.1038\/s41467-023-44067-4. Published 2023 Dec 14.","journal-title":"Nat Commun"},{"issue":"10","key":"311_CR8","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1164\/rccm.202303-0491OC","volume":"208","author":"D Foer","year":"2023","unstructured":"Foer D, Strasser ZH, Cui J, et al. Association of GLP-1 Receptor Agonists with Chronic Obstructive Pulmonary Disease Exacerbations among Patients with Type 2 Diabetes. Am J Respir Crit Care Med. 2023;208(10):1088\u2013100. https:\/\/doi.org\/10.1164\/rccm.202303-0491OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"311_CR9","first-page":"439","volume":"122","author":"T Liu","year":"2019","unstructured":"Liu T, et al. Anaphylaxis following a single dose of dulaglutide: a case report. Ann Allergy Asthma Immunol. 2019;122(4):439\u201340.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9","key":"311_CR10","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.2337\/dc19-0720","volume":"42","author":"O Shamriz","year":"2019","unstructured":"Shamriz O, NaserEddin A, Mosenzon O, Sviri S, Tal Y. Allergic Reaction to Exenatide and Lixisenatide but Not to Liraglutide: Unveiling Anaphylaxis to Glucagon-Like Peptide 1 Receptor Agonists. Diabetes Care. 2019;42(9):e141\u20132. https:\/\/doi.org\/10.2337\/dc19-0720.","journal-title":"Diabetes Care"},{"issue":"1","key":"311_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/thorax-2024-221906","volume":"80","author":"AE Henney","year":"2024","unstructured":"Henney AE, Riley DR, Hydes TJ, et al. Comparative estimate of glucose-lowering therapies on risk of incident pneumonia and severe sepsis: an analysis of real-world cohort data. Thorax. 2024;80(1):32\u201341. https:\/\/doi.org\/10.1136\/thorax-2024-221906. Published 2024 Dec 23.","journal-title":"Thorax"},{"key":"311_CR12","doi-asserted-by":"publisher","unstructured":"Fishman CE, Walshe C, Claridge T, et al. Tolerability and effectiveness of glucagon-like peptide-1 receptor agonists in lung transplant recipients: a single center report. Transplant Proc. 2025;57(2):342\u2013347. https:\/\/doi.org\/10.1016\/j.transproceed.2024.11.016.","DOI":"10.1016\/j.transproceed.2024.11.016"},{"issue":"2","key":"311_CR13","first-page":"1093","volume":"4","author":"C Askin","year":"2016","unstructured":"Askin C, et al. Acute eosinophilic pneumonia due to extended-release exenatide: a case report. JSM Clin Case Rep. 2016;4(2):1093.","journal-title":"JSM Clin Case Rep"},{"issue":"2","key":"311_CR14","doi-asserted-by":"publisher","first-page":"252","DOI":"10.2337\/dc11-1107","volume":"35","author":"D Russell-Jones","year":"2012","unstructured":"Russell-Jones D, Cuddihy RM, Hanefeld M, et al. Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study. Diabetes Care. 2012;35(2):252\u20138. https:\/\/doi.org\/10.2337\/dc11-1107.","journal-title":"Diabetes Care"},{"issue":"5","key":"311_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1177\/8755122514539462","volume":"30","author":"EH Steveling","year":"2014","unstructured":"Steveling EH, Winzeler B, Bircher AJ. Systemic Allergic Reaction to the GLP-1 Receptor Agonist Exenatide. J Pharm Technol. 2014;30(5):182\u20136. https:\/\/doi.org\/10.1177\/8755122514539462.","journal-title":"J Pharm Technol"},{"issue":"6","key":"311_CR16","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s10557-024-07613-w","volume":"39","author":"M Nakhla","year":"2025","unstructured":"Nakhla M, Nair A, Balani P, et al. Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study. Cardiovasc Drugs Ther. 2025;39(6):1331\u201341. https:\/\/doi.org\/10.1007\/s10557-024-07613-w.","journal-title":"Cardiovasc Drugs Ther"},{"key":"311_CR17","unstructured":"Rehan M, et al. Acute respiratory distress syndrome associated with GLP-1 receptor agonist exposure: a fatal case [conference abstract]. Am J Respir Crit Care Med. 2024."},{"key":"311_CR18","doi-asserted-by":"publisher","unstructured":"Avraham SA, Hossein J, Somri F, Hawash N, Hochman O. Pulmonary aspiration of gastric contents in two patients taking semaglutide for weight loss. Anaesth Rep. 2024;12(1):e12278. Published 2024 Jan 14. https:\/\/doi.org\/10.1002\/anr3.12278.","DOI":"10.1002\/anr3.12278"},{"issue":"3","key":"311_CR19","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/wjs.12484","volume":"49","author":"Z Rashid","year":"2025","unstructured":"Rashid Z, Woldesenbet S, Khalil M, et al. Impact of Preoperative Glucagon-Like Peptide-1 Receptor Agonist on Outcomes Following Major Surgery. World J Surg. 2025;49(3):698\u2013707. https:\/\/doi.org\/10.1002\/wjs.12484.","journal-title":"World J Surg"},{"key":"311_CR20","doi-asserted-by":"publisher","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","volume":"88","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906. https:\/\/doi.org\/10.1016\/j.ijsu.2021.105906.","journal-title":"Int J Surg"},{"key":"311_CR21","doi-asserted-by":"publisher","unstructured":"Campbell M, McKenzie JE, Sowden A, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ. 2020;368:l6890. Published 2020 Jan 16. https:\/\/doi.org\/10.1136\/bmj.l6890.","DOI":"10.1136\/bmj.l6890"},{"issue":"4","key":"311_CR22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.026.","journal-title":"J Clin Epidemiol"}],"container-title":["Cardiovascular Diabetology \u2013 Endocrinology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-026-00311-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40842-026-00311-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-026-00311-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:02:20Z","timestamp":1781820140000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40842-026-00311-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["311"],"URL":"https:\/\/doi.org\/10.1186\/s40842-026-00311-6","relation":{},"ISSN":["3059-4057"],"issn-type":[{"value":"3059-4057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"27 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study is a systematic review of previously published data and does not involve human participants or patient-level identifiable data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}